Subscription Center
Mar 9, 2009 | 16
President Obama today lifted an eight-year-old ban on embryonic stem cell research, signing an executive order that he called "an important step in advancing the cause of science in America."
"We will vigorously support scientists who pursue this research," Obama said at a signing ceremony in the White House. "And we will aim for America to lead the world in the discoveries it one day may yield."
Obama's order ends former President George W. Bush's limit on federally funded embryonic stem-cell research to cell lines created before Aug. 9, 2001. Congress tried twice to reverse that ban, and his National Institutes of Health (NIH) director, Elias Zerhouni, urged an end to the restrictions, but Bush vetoed the legislation both times.
Nov 7, 2008 | 1
Scientists got nerve cells in mice to regenerate by knocking out genes that halt cell growth, a possible step toward treating brain and spinal cord injuries, according to new research.
Neurons in the central nervous system typically can't grow again once they've matured, and the pathway that regulates their development is silenced when those cells are injured. Researchers at Children's Hospital Boston shut off two genes that inhibit cell growth, then watched to see whether crushed optic nerves in the mice would survive.
Two weeks later, up to 45 percent of the injured neurons were still alive, compared with about 20 percent in the mice that didn’t receive the gene deletions, according to the report in this week's Science. About 8 to 10 percent of the surviving neurons regenerated, an effect seen up to four weeks after the mice were injured.
Oct 20, 2008 | 4
A clinical trial that would test the use of embryonic stem cells to treat spinal cord injury could begin within three months.
The Scientist is reporting that the Food and Drug Administration (FDA) may lift its hold on a trial sponsored by California biotech Geron Corp. by early next year. In May, the agency ordered Geron to delay the trial while it studied how best to regulate stem-cell-based therapies.
The phase 1 trial would test whether it is safe to inject nerve cells into the site of a spinal cord injury. A study published in 2005 in the Journal of Neuroscience found that giving rats the injections seven days after a spinal cord injury improved their motor function.
See what we're tweeting about
johnrplatt An update on the island foxes I wrote about a few weeks ago: http://t.co/hKH3Wbx9Dk johnrplatt Efforts Made to Recover Kunza Language, Once Thought Extinct http://t.co/ydirInelf0
JenLucPiquant Skeletons and monstrous lambs: remembering the historians of the Royal Society: http://t.co/iVMjTQKwuf
Deadline: Jun 29 2013
Reward: $7,000 USD
The Seeker for this Challenge desires proposals for chemical methods that could rapidly degrade a dilute aqueous solution
Deadline: Jul 25 2013
Reward: Varies
This challenge provides an opportunity for Solvers to build a web-based or mobile “app” to explore data relationships in scholarly conte
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
